|
Notes: I.
Recombinant Protein A.
Recombinant Protein with 6x His- tag at
N-terminus, purity >90% determined by SDS-PAGE B.
Applications: SDS-PAGE or Western blot. It may be used for
other applications determined by user. II.
Codon -optimized cDNA sequence A.
Artificially synthesized Codon
-optimized cDNA sequence designed for recombinant protein production in both
of E.coli and mammalian cell. The cDNAs have been cloned into E.coli expression vector with 6x His- tag at
N-terminus. B.
May be used as RNAi assistance to
restore the loss-of-function. |
Recombinant Protein |
Codon -optimized cDNA
Sequence |
|||
|
Recombinant
Protein Produced from E.coli |
Recombinant
Protein Produced from Insect cell |
Expression-ready
clone( E.coli Expression) |
|||
|
Product |
Protein names |
Cat# / Price |
Cat# / Price |
Cat# / Price (10µg Plasmid
DNA) |
|
|
MUCL1
(SBEM) (UNQ590/PRO1160) |
PE-0401 100
µg/$1195 500
µg/$2950 |
PEP-0401 |
REP-0401 10µg/$800 |
||
|
Fibronectin (FN) (Cold-insoluble
globulin) (CIG) [Cleaved into: Anastellin ; Ugl-Y1;
Ugl-Y2; Ugl-Y3] |
PE-0402 100
µg/$1195 500
µg/$2950 |
PEP-0402 |
REP-0402 10µg/$800 |
||
|
Protein
S100-A1 (S100 calcium-binding protein A1) (S-100 protein subunit alpha)
(S-100 protein alpha chain) |
PE-0403 100
µg/$1195 500
µg/$2950 |
PEP-0403 |
REP-0403 10µg/$800 |
||
|
Neuropeptide Y [Cleaved into: Neuropeptide Y ( Neuropeptide
tyrosine) (NPY); C-flanking peptide of NPY (CPON)] |
PE-0404 100
µg/$1195 500
µg/$2950 |
PEP-0404 |
REP-0404 10µg/$800 |
||
|
Interleukin-8
(IL-8) (C-X-C motif chemokine 8) ( Monocyte -derived neutrophil chemotactic factor) (MDNCF) (T-cell chemotactic
factor) ( Neutrophil -activating protein 1) (NAP-1)
(Protein 3-10C) (Granulocyte chemotactic protein 1)
(GCP-1) ( Monocyte -derived neutrophil
-activating peptide) (MONAP) ( Emoctakin ) |
PE-0405 100
µg/$1195 500
µg/$2950 |
PEP-0405 |
REP-0405 10µg/$800 |
||
|
Ubiquitin -protein ligase
E3A (EC 6.3.2.-) (E6AP ubiquitin -protein ligase ) ( Oncogenic
protein-associated protein E6-AP) (Human papillomavirus
E6-associated protein) (Renal carcinoma antigen NY-REN-54) |
PE-0406 100
µg/$1195 500
µg/$2950 |
PEP-0406 |
REP-0406 10µg/$800 |
||
|
Prolow -density lipoprotein receptor-related
protein 1 (LRP) (Alpha-2-macroglobulin receptor) (A2MR) ( Apolipoprotein
E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein
receptor-related protein 1 85 kDa subunit |
PE-0407 100
µg/$1195 500
µg/$2950 |
PEP-0407 |
REP-0407 10µg/$800 |
||
|
Insulin
receptor substrate 1 (IRS-1) |
PE-0408 100
µg/$1195 500
µg/$2950 |
PEP-0408 |
REP-0408 10µg/$800 |
||
|
Cytochrome c |
PE-0409 100
µg/$1195 500
µg/$2950 |
PEP-0409 |
REP-0409 10µg/$800 |
||
|
Thioredoxin ( Trx
) (ATL-derived factor) (ADF) (Surface-associated sulphydryl
protein) (SASP) |
PE-0410 100
µg/$1195 500
µg/$2950 |
PEP-0410 |
REP-0410 10µg/$800 |
||
|
Macrophage
migration inhibitory factor (MIF) (EC 5.3.2.1) ( Phenylpyruvate
tautomerase ) (L- dopachrome
tautomerase ) (EC 5.3.3.12) (L- dopachrome
isomerase ) ( Glycosylation
-inhibiting factor) (GIF) |
PE-0411 100
µg/$1195 500
µg/$2950 |
PEP-0411 |
REP-0411 10µg/$800 |
||
|
Beta-2-microglobulin
[Cleaved into: Beta-2-microglobulin form pI 5.3] |
PE-0412 100
µg/$1195 500
µg/$2950 |
PEP-0412 |
REP-0412 10µg/$800 |
||
|
Histone -lysine N- methyltransferase
MLL (EC 2.1.1.43) (Zinc finger protein HRX) (ALL-1) ( Trithorax
-like protein) (Lysine N- methyltransferase 2A)
(CXXC-type zinc finger protein 7) |
PE-0413 100
µg/$1195 500
µg/$2950 |
PEP-0413 |
REP-0413 10µg/$726 |
||
|
PSCA
(UNQ206/PRO232) |
PE-0414 100
µg/$1195 500
µg/$2950 |
PEP-0414 |
REP-0414 10µg/$800 |
||
|
WFDC2
(HE4) (WAP5) |
PE-0415 100
µg/$1195 500
µg/$2950 |
PEP-0415 |
REP-0415 10µg/$800 |
||
|
GALNT3 |
PE-0416 100
µg/$1195 500
µg/$2950 |
PEP-0416 |
REP-0416 10µg/$756 |
||
|
CD59
glycoprotein (Membrane attack complex inhibition factor) (MACIF)
(MAC-inhibitory protein) (MAC-IP) ( Protectin )
(MEM43 antigen) (Membrane inhibitor of reactive lysis
) (MIRL) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (1F5
antigen) (CD antigen CD59) |
PE-0417 100
µg/$1195 500
µg/$2950 |
PEP-0417 |
REP-0417 10µg/$800 |
||
|
Protein-glutamine
gamma- glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase ) ( TGase C)
(TGC) (TG(C)) (Transglutaminase-2) ( TGase -H) |
PE-0418 100
µg/$1195 500
µg/$2950 |
PEP-0418 |
REP-0418 10µg/$828 |
||
|
Baculoviral IAP repeat-containing
protein 5 (Apoptosis inhibitor survivin )
(Apoptosis inhibitor 4) |
PE-0419 100
µg/$1195 500
µg/$2950 |
PEP-0419 |
REP-0419 10µg/$846 |
||
|
Alsin (Amyotrophic lateral sclerosis
protein 2) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene
6 protein) |
PE-0420 100
µg/$1195 500
µg/$2950 |
PEP-0420 |
REP-0420 10µg/$864 |
||
|
Hemoglobin
subunit beta (Hemoglobin beta chain) (Beta- globin
) [Cleaved into: LVV-hemorphin-7] |
PE-0421 100
µg/$1195 500
µg/$2950 |
PEP-0421 |
REP-0421 10µg/$870 |
||
|
Transthyretin ( Prealbumin
) (TBPA) (TTR) (ATTR) |
PE-0422 100
µg/$1195 500
µg/$2950 |
PEP-0422 |
REP-0422 10µg/$756 |
||
|
Superoxide
dismutase [Cu-Zn] (EC 1.15.1.1) |
PE-0423 100
µg/$1195 500
µg/$2950 |
PEP-0423 |
REP-0423 10µg/$912 |
||
|
Low
molecular weight phosphotyrosine protein phosphatase (LMW- PTPase )
(LMW-PTP) (EC 3.1.3.48) (Low molecular weight cytosolic
acid phosphatase ) (EC 3.1.3.2) (Red cell acid phosphatase 1) ( Adipocyte acid
phosphatase ) |
PE-0424 100
µg/$1195 500
µg/$2950 |
PEP-0424 |
REP-0424 10µg/$936 |
||
|
Epithelial
membrane protein 3 (EMP-3) (Protein YMP) (Hematopoietic neural membrane
protein) (HNMP-1) |
PE-0425 100
µg/$1195 500
µg/$2950 |
PEP-0425 |
REP-0425 10µg/$798 |
||
|
Peptidyl-prolyl cis
-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) ( Rotamase Pin1) ( PPIase Pin1) |
PE-0426 100
µg/$1195 500
µg/$2950 |
PEP-0426 |
REP-0426 10µg/$972 |
||
|
Cyclin -dependent kinase
inhibitor 1 (p21) (CDK-interacting protein 1) (Melanoma
differentiation-associated protein 6) (MDA-6) |
PE-0427 100
µg/$1195 500
µg/$2950 |
PEP-0427 |
REP-0427 10µg/$972 |
||
|
Growth
arrest and DNA-damage-inducible protein GADD45 alpha (DNA-damage-inducible
transcript 1) (DDIT-1) |
PE-0428 100
µg/$1195 500
µg/$2950 |
PEP-0428 |
REP-0428 10µg/$984 |
||
|
PIAS1
(DDXBP1) |
PE-0429 100
µg/$1195 500
µg/$2950 |
PEP-0429 |
REP-0429 10µg/$984 |
||
|
Bcl2
antagonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like
protein 8) (Bcl2-L-8) ( Bcl -XL/Bcl-2-associated
death promoter) |
PE-0430 100
µg/$1195 500
µg/$2950 |
PEP-0430 |
REP-0430 10µg/$1002 |
||
|
Succinate dehydrogenase
cytochrome b560 subunit, mitochondrial ( Succinate dehydrogenase complex
subunit C) (Integral membrane protein CII-3) (QPs-1) (QPs1) ( Succinate-ubiquinone oxidoreductase
cytochrome B large subunit) (CYBL) |
PE-0431 100
µg/$1195 500
µg/$2950 |
PEP-0431 |
REP-0431 10µg/$834 |
||
|
TNS3
(TEM6) (TENS1) (TPP) |
PE-0432 100
µg/$1195 500
µg/$2950 |
PEP-0432 |
REP-0432 10µg/$1014 |
||
|
VWA2
(AMACO) |
PE-0433 100
µg/$1195 500
µg/$2950 |
PEP-0433 |
REP-0433 10µg/$1026 |
||
|
Cyclin -dependent kinase
inhibitor 2A, isoform 4 (p14ARF) (p19ARF) |
PE-0434 100
µg/$1195 500
µg/$2950 |
PEP-0434 |
REP-0434 10µg/$1032 |
||
|
Alpha-
crystallin B chain (Alpha(B)- crystallin
) (Rosenthal fiber component) (Heat shock protein beta-5) (HspB5) (Renal
carcinoma antigen NY-REN-27) |
PE-0435 100
µg/$1195 500
µg/$2950 |
PEP-0435 |
REP-0435 10µg/$1044 |
||
|
Bloom
syndrome protein (EC 3.6.1.-) ( RecQ protein-like
3) (DNA helicase , RecQ
-like type 2) |
PE-0436 100
µg/$1195 500
µg/$2950 |
PEP-0436 |
REP-0436 10µg/$1050 |
||
|
DNA
excision repair protein ERCC-6 (EC 3.6.1.-) (ATP-dependent helicase ERCC6) ( Cockayne
syndrome protein CSB) |
PE-0437 100
µg/$1195 500
µg/$2950 |
PEP-0437 |
REP-0437 10µg/$1056 |
||
|
Caveolin-1 |
PE-0438 100
µg/$1195 500
µg/$2950 |
PEP-0438 |
REP-0438 10µg/$1056 |
||
|
Mediator
of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28)
(Tumor angiogenesis marker EG-1) (Endothelial-derived protein 1) (Merlin and
Grb2-interacting cytoskeletal protein) ( Magicin ) |
PE-0439 100
µg/$1195 500
µg/$2950 |
PEP-0439 |
REP-0439 10µg/$1062 |
||
|
CSPG4
(MCSP) |
PE-0440 100
µg/$1195 500
µg/$2950 |
PEP-0440 |
REP-0440 10µg/$1068 |
||
|
Proto-oncogene
vav |
PE-0441 100
µg/$1195 500
µg/$2950 |
PEP-0441 |
REP-0441 10µg/$1074 |
||
|
FAM129A
(C1orf24) (NIBAN) (GIG39) |
PE-0442 100
µg/$1195 500
µg/$2950 |
PEP-0442 |
REP-0442 10µg/$1086 |
||
|
Apolipoprotein D (Apo-D) ( ApoD ) |
PE-0443 100
µg/$1195 500
µg/$2950 |
PEP-0443 |
REP-0443 10µg/$1008 |
||
|
Protein
DJ-1 ( Oncogene DJ1) (Parkinson disease protein 7) |
PE-0444 100
µg/$1195 500
µg/$2950 |
PEP-0444 |
REP-0444 10µg/$1128 |
||
|
GTPase HRas
(Transforming protein p21) (p21ras) (H-Ras-1) (c-H- ras
) (Ha- Ras ) [Cleaved into: GTPase
HRas , N-terminally processed] |
PE-0445 100
µg/$1195 500
µg/$2950 |
PEP-0445 |
REP-0445 10µg/$1110 |
||
|
Phosphatidylinositol 3-kinase regulatory
subunit alpha (PI3-kinase p85 subunit alpha) (PtdIns-3-kinase p85-alpha)
(PI3K) |
PE-0446 100
µg/$1195 500
µg/$2950 |
PEP-0446 |
REP-0446 10µg/$1128 |
||
|
ARHGEF17
(KIAA0337) (TEM4) |
PE-0447 100
µg/$1195 500
µg/$2950 |
PEP-0447 |
REP-0447 10µg/$1128 |
||
|
FN1
(FN) |
PE-0448 100
µg/$1195 500
µg/$2950 |
PEP-0448 |
REP-0448 10µg/$1128 |
||
|
Prostaglandin-H2
D- isomerase (EC 5.3.99.2) ( Lipocalin
-type prostaglandin-D synthase )
(Glutathione-independent PGD synthetase )
(Prostaglandin-D2 synthase ) (PGD2 synthase ) (PGDS2) (PGDS) (Beta-trace protein)
(Cerebrin-28) |
PE-0449 100
µg/$1195 500
µg/$2950 |
PEP-0449 |
REP-0449 10µg/$1002 |
||
|
Cell
division control protein 42 homolog (G25K GTP-binding protein) |
PE-0450 100
µg/$1195 500
µg/$2950 |
PEP-0450 |
REP-0450 10µg/$1122 |
||
|
Apoptosis
regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4) |
PE-0451 100
µg/$1195 500
µg/$2950 |
PEP-0451 |
REP-0451 10µg/$1026 |
||
|
Ras -related C3 botulinum toxin substrate
1 (p21-Rac1) ( Ras -like protein TC25) (Cell
migration-inducing gene 5 protein) |
PE-0452 100
µg/$1195 500
µg/$2950 |
PEP-0452 |
REP-0452 10µg/$1128 |
||
|
Erythropoietin
( Epoetin ) |
PE-0453 100
µg/$1195 500
µg/$2950 |
PEP-0453 |
REP-0453 10µg/$990 |
||
|
Transforming
protein RhoA (H12) |
PE-0454 100
µg/$1195 500
µg/$2950 |
PEP-0454 |
REP-0454 10µg/$1134 |
||
|
Insulin
receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin
receptor subunit alpha; Insulin receptor subunit beta] |
PE-0455 100
µg/$1195 500
µg/$2950 |
PEP-0455 |
REP-0455 10µg/$1158 |
||
|
Insulin-like
growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I
receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like
growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor
beta chain] |
PE-0456 100
µg/$1195 500
µg/$2950 |
PEP-0456 |
REP-0456 10µg/$1164 |
||
|
Corticoliberin ( Corticotropin
-releasing hormone) ( Corticotropin -releasing
factor) (CRF) |
PE-0457 100
µg/$1195 500
µg/$2950 |
PEP-0457 |
REP-0457 10µg/$768 |
||
|
Breast
cancer type 2 susceptibility protein ( Fanconi
anemia group D1 protein) |
PE-0458 100
µg/$1195 500
µg/$2950 |
PEP-0458 |
REP-0458 10µg/$1170 |
||
|
Cyclin -dependent kinase
inhibitor 1B ( Cyclin -dependent kinase inhibitor p27) (p27Kip1) |
PE-0459 100
µg/$1195 500
µg/$2950 |
PEP-0459 |
REP-0459 10µg/$912 |
||
|
Thrombospondin-1 |
PE-0460 100
µg/$1195 500
µg/$2950 |
PEP-0460 |
REP-0460 10µg/$1182 |
||
|
Leukemia
inhibitory factor (LIF) (Differentiation-stimulating factor) (D factor)
(Melanoma-derived LPL inhibitor) (MLPLI) ( Emfilermin
) |
PE-0461 100
µg/$1195 500
µg/$2950 |
PEP-0461 |
REP-0461 10µg/$1074 |
||
|
TACC2 |
PE-0462 100
µg/$1195 500
µg/$2950 |
PEP-0462 |
REP-0462 10µg/$1206 |
||
|
Heat
shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27)
(Stress-responsive protein 27) (SRP27) (Estrogen-regulated 24 kDa protein)
(28 kDa heat shock protein) |
PE-0463 100
µg/$1195 500
µg/$2950 |
PEP-0463 |
REP-0463 10µg/$1224 |
||
|
Lymphotoxin -alpha (LT-alpha)
(TNF-beta) (Tumor necrosis factor ligand superfamily member 1) |
PE-0464 100
µg/$1195 500
µg/$2950 |
PEP-0464 |
REP-0464 10µg/$1020 |
||
|
Methylated -DNA--protein- cysteine
methyltransferase (EC 2.1.1.63)
(6-O-methylguanine-DNA methyltransferase ) (MGMT)
(O-6-methylguanine-DNA-alkyltransferase) |
PE-0465 100
µg/$1195 500
µg/$2950 |
PEP-0465 |
REP-0465 10µg/$1236 |
||
|
Metalloproteinase
inhibitor 1 (Tissue inhibitor of metalloproteinases
) (TIMP-1) ( Erythroid -potentiating activity) (EPA)
(Fibroblast collagenase inhibitor) ( Collagenase inhibitor) |
PE-0466 100
µg/$1195 500
µg/$2950 |
PEP-0466 |
REP-0466 10µg/$1098 |
||
|
MIG7 |
PE-0467 100
µg/$1195 500
µg/$2950 |
PEP-0467 |
REP-0467 10µg/$1236 |
||
|
Protein
FADD (FAS-associated death domain protein) (FAS-associating death
domain-containing protein) (Mediator of receptor induced toxicity)
(Growth-inhibiting gene 3 protein) |
PE-0468 100
µg/$1195 500
µg/$2950 |
PEP-0468 |
REP-0468 10µg/$1242 |
||
|
ANO1
(DOG1) (ORAOV2) (TAOS2) (TMEM16A) |
PE-0469 100
µg/$1195 500
µg/$2950 |
PEP-0469 |
REP-0469 10µg/$618 |
||
|
Glutathione
S- transferase P (EC 2.5.1.18) (GST class-pi)
(GSTP1-1) |
PE-0470 100
µg/$1195 500
µg/$2950 |
PEP-0470 |
REP-0470 10µg/$1248 |
||
|
Von
Hippel-Lindau disease tumor suppressor ( pVHL ) (Protein G7) |
PE-0471 100
µg/$1195 500
µg/$2950 |
PEP-0471 |
REP-0471 10µg/$1272 |
||
|
EBAG9
(RCAS1) |
PE-0472 100
µg/$1195 500
µg/$2950 |
PEP-0472 |
REP-0472 10µg/$1110 |
||
|
Fragile
X mental retardation 1 protein (Protein FMR-1) (FMRP) |
PE-0473 100
µg/$1195 500
µg/$2950 |
PEP-0473 |
REP-0473 10µg/$1278 |
||
|
High
mobility group protein B1 (High mobility group protein 1) (HMG-1) |
PE-0474 100
µg/$1195 500
µg/$2950 |
PEP-0474 |
REP-0474 10µg/$1278 |
||
|
Growth
factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2)
(Protein Ash) |
PE-0475 100
µg/$1195 500
µg/$2950 |
PEP-0475 |
REP-0475 10µg/$1296 |
||
|
Neurofibromin
(Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin
truncated] |
PE-0476 100
µg/$1195 500
µg/$2950 |
PEP-0476 |
REP-0476 10µg/$1296 |
||
|
Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal
muscle-type ryanodine receptor) (Skeletal muscle
calcium release channel) |
PE-0477 100
µg/$1195 500
µg/$2950 |
PEP-0477 |
REP-0477 10µg/$1296 |
||
|
Glutathione
S- transferase Mu 1 (EC 2.5.1.18) (GSTM1-1) (GST
class-mu 1) (GSTM1a-1a) (GSTM1b-1b) (HB subunit 4) (GTH4) |
PE-0478 100
µg/$1195 500
µg/$2950 |
PEP-0478 |
REP-0478 10µg/$1296 |
||
|
Hypoxanthine-guanine
phosphoribosyltransferase ( HGPRTase
) (HGPRT) (EC 2.4.2.8) |
PE-0479 100
µg/$1195 500
µg/$2950 |
PEP-0479 |
REP-0479 10µg/$1302 |
||
|
Superoxide
dismutase [ Mn ], mitochondrial (EC 1.15.1.1) |
PE-0480 100
µg/$1195 500
µg/$2950 |
PEP-0480 |
REP-0480 10µg/$1182 |
||
|
CHMP2A
(BC2) (CHMP2) |
PE-0481 100
µg/$1195 500
µg/$2950 |
PEP-0481 |
REP-0481 10µg/$996 |
||
|
Ubiquitin carboxyl-terminal hydrolase
isozyme L1 (UCH-L1) (EC 3.4.19.12) (EC 6.-.-.-) ( Ubiquitin thioesterase L1) (Neuron
cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) |
PE-0482 100
µg/$1195 500
µg/$2950 |
PEP-0482 |
REP-0482 10µg/$1332 |
||
|
Pro-neuregulin-1,
membrane-bound isoform (Pro-NRG1) [Cleaved into:
Neuregulin-1 ( Neu differentiation factor) ( Heregulin ) (HRG) (Breast cancer cell differentiation
factor p45) (Acetylcholine receptor-inducing activity) (ARIA) (Sensory and
motor neuron-derived factor) ( Glial growth
factor)] |
PE-0483 100
µg/$1195 500
µg/$2950 |
PEP-0483 |
REP-0483 10µg/$1332 |
||
|
Canalicular multispecific
organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multidrug
resistance-associated protein 3) (Multi-specific organic anion transporter D)
(MOAT-D) |
PE-0484 100
µg/$1195 500
µg/$2950 |
PEP-0484 |
REP-0484 10µg/$1332 |
||
|
Breast
cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53) |
PE-0485 100
µg/$1195 500
µg/$2950 |
PEP-0485 |
REP-0485 10µg/$1332 |
||
|
C-reactive
protein [Cleaved into: C-reactive protein(1-205)] |
PE-0486 100
µg/$1195 500
µg/$2950 |
PEP-0486 |
REP-0486 10µg/$1230 |
||
|
Cystic
fibrosis transmembrane conductance regulator (CFTR)
(Channel conductance-controlling ATPase ) (EC
3.6.3.49) ( cAMP -dependent chloride channel)
(ATP-binding cassette transporter sub-family C member 7) |
PE-0487 100
µg/$1195 500
µg/$2950 |
PEP-0487 |
REP-0487 10µg/$1338 |
||
|
Ataxin-1
( Spinocerebellar ataxia type 1 protein) |
PE-0488 100
µg/$1195 500
µg/$2950 |
PEP-0488 |
REP-0488 10µg/$1356 |
||
|
Poly
[ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADPRT) (NAD(+) ADP- ribosyltransferase 1) (Poly[ADP-ribose] synthetase 1) |
PE-0489 100
µg/$1195 500
µg/$2950 |
PEP-0489 |
REP-0489 10µg/$1356 |
||
|
Androgen
receptor ( Dihydrotestosterone receptor) (Nuclear
receptor subfamily 3 group C member 4) |
PE-0490 100
µg/$1195 500
µg/$2950 |
PEP-0490 |
REP-0490 10µg/$1374 |
||
|
Vascular
endothelial growth factor A (VEGF-A) (Vascular permeability factor) (VPF) |
PE-0491 100
µg/$1195 500
µg/$2950 |
PEP-0491 |
REP-0491 10µg/$1230 |
||
|
Bcl-2-like
protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl -X) |
PE-0492 100
µg/$1195 500
µg/$2950 |
PEP-0492 |
REP-0492 10µg/$1254 |
||
|
Hepatocyte growth factor (Scatter factor) (SF) (
Hepatopoeitin -A) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte
growth factor beta chain] |
PE-0493 100
µg/$1195 500
µg/$2950 |
PEP-0493 |
REP-0493 10µg/$1398 |
||
|
T-cell
surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen
T8/Leu-2) (CD antigen CD8a) |
PE-0494 100
µg/$1195 500
µg/$2950 |
PEP-0494 |
REP-0494 10µg/$960 |
||
|
Multidrug
resistance-associated protein 1 (ATP-binding cassette sub-family C member 1)
( Leukotriene C(4) transporter) (LTC4 transporter) |
PE-0495 100
µg/$1195 500
µg/$2950 |
PEP-0495 |
REP-0495 10µg/$1404 |
||
|
Collagen
alpha-1(I) chain (Alpha-1 type I collagen) |
PE-0496 100
µg/$1195 500
µg/$2950 |
PEP-0496 |
REP-0496 10µg/$1410 |
||
|
Apoptosis
regulator Bcl-2 |
PE-0497 100
µg/$1195 500
µg/$2950 |
PEP-0497 |
REP-0497 10µg/$1266 |
||
|
Filamin -B (FLN-B) (Beta- filamin
) ( Actin -binding-like protein) (Thyroid autoantigen ) (Truncated actin
-binding protein) (Truncated ABP) (ABP-280 homolog) (ABP-278) ( Filamin 3) ( Filamin homolog 1)
(Fh1) |
PE-0498 100
µg/$1195 500
µg/$2950 |
PEP-0498 |
REP-0498 10µg/$1428 |
||
|
Glutathione
S- transferase theta-1 (EC 2.5.1.18) (GST
class-theta-1) (Glutathione transferase T1-1) |
PE-0499 100
µg/$1195 500
µg/$2950 |
PEP-0499 |
REP-0499 10µg/$1428 |
||
|
Dystrophin |
PE-0500 100
µg/$1195 500
µg/$2950 |
PEP-0500 |
REP-0500 10µg/$1434 |
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||
| |||||||||||||
| *** For cDNA or Recombinant Protein Search ( Input Gene name, or Protein Name, or Swiss -prot Accession Number) |
